Review
Published on 27 Jan 2025
The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1455867
Type at least 3 characters
1,336 articles
Articles
Case Report
Published on 24 Jan 2025
Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1498847
- 256 views
Original Research
Published on 24 Jan 2025
Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1516909
- 298 views
Original Research
Published on 23 Jan 2025
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1515730
- 233 views
Original Research
Published on 22 Jan 2025
Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1519700
- 213 views
Correction
Accepted on 20 Jan 2025
Corrigendum: Brain-Specific Increase in Leukotriene Signaling Accompanies Chronic Neuroinflammation and Cognitive Impairment in a Model of Gulf War Illness
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557065
Case Report
Accepted on 20 Jan 2025
Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1535782
- 649 views
Original Research
Accepted on 20 Jan 2025
Assessing the inflammation in Pediatric MOGAD: Significance of CSF HMGB1 and Related Biomarkers
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1534172
Case Report
Published on 17 Jan 2025
Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1517943
- 205 views
Systematic Review
Published on 17 Jan 2025
Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1491880
- 189 views
Original Research
Accepted on 16 Jan 2025
Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1508977
Original Research
Accepted on 16 Jan 2025
Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532660
Original Research
Accepted on 15 Jan 2025
Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1520188
Original Research
Accepted on 15 Jan 2025
Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1505459
- 120 views
Original Research
Published on 14 Jan 2025
Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1522381
- 462 views
Case Report
Published on 14 Jan 2025
Case report: Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1461024
- 195 views